本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Precision Biosciences Inc

7.15
-0.0200-0.28%
成交量:4.31萬
成交額:30.81萬
市值:1.97億
市盈率:-2.55
高:7.21
開:7.13
低:7.05
收:7.17
52周最高:9.62
52周最低:3.53
股本:2,760.16萬
流通股本:2,525.67萬
量比:1.34
換手率:0.17%
股息:- -
股息率:- -
每股收益(TTM):-2.8007
每股收益(LYR):-3.5649
淨資產收益率:-135.15%
總資產收益率:-19.37%
市淨率:4.36
市盈率(LYR):-2.01

資料載入中...

2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/16

重要事件披露

Form 8-K - Current report
2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/18

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/01

重要事件披露

Form 8-K - Current report
2024/03/01

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/24

重要事件披露

Form 8-K - Current report
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities